½ÃÀ庸°í¼­
»óǰÄÚµå
1451626

°£Çæ½Ä Ä«Å×ÅÍ ½ÃÀå º¸°í¼­ : Á¦Ç°, ÀûÀÀÁõ, Ä«Å×°í¸®, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°(2024-2032³â)

Intermittent Catheters Market Report by Product, Indication (Urinary Incontinence, Surgery, Spinal Cord Injury, and Others), Category, End User, and Region 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 146 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ °£Çæ½Ä Ä«Å×ÅÍ ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 27¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº ½ÃÀåÀÌ 2032³â±îÁö 47¾ï ´Þ·¯¿¡ ´ÞÇϸç, 2024-2032³â 6.02%ÀÇ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù.

°£Çæ½Ä Ä«Å×ÅÍ ¿ä¹ýÀº ¹æ±¤¿¡¼­ ¼Òº¯À» ¹èÃâÇϱâ À§ÇØ Ä«Å×Å͸¦ »ðÀÔÇϰí Á¦°ÅÇÏ´Â ¹æ¹ýÀÔ´Ï´Ù. Ư¹ß¼º ¶Ç´Â ½Å°æÀμº ¹æ±¤ °úȰµ¿¼º(NDO) ±â´É Àå¾Ö, ¿°Áõ, ½Å°æÇÐÀû »óÅÂ, ¾à¸®ÇÐÀû ¾à¹°, ¹°¸®Àû ¹æ±¤ Æó»öÀ¸·Î ÀÎÇØ ¹æ±¤ ¹èÃâÀÌ ºÒ¿ÏÀüÇÑ È¯ÀÚ¿¡°Ô È¿°úÀûÀÎ ¹æ±¤ °ü¸® Àü·«ÀÔ´Ï´Ù. ¹æ±¤ ÆØÃ¢°ú ¿ä·Î°¨¿°(UTI)À» ¿¹¹æÇϸ鼭 »ç¿ëÇϱ⠽±°í Æí¸®ÇÕ´Ï´Ù. ¶ÇÇÑ ´©Ãâ, ¸·Èû ¹× ¹æ±¤ °æ·ÃÀ» ÇÇÇÒ ¼ö ÀÖÀ¸¹Ç·Î °£Çæ½Ä Ä«Å×ÅÍ¿¡ ´ëÇÑ ¼ö¿ä°¡ Àü ¼¼°è¿¡¼­ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

°£Çæ½Ä Ä«Å×ÅÍ ½ÃÀå µ¿Çâ :

ÇöÀç Àü ¼¼°è¿¡¼­ ¿ä·Î°¨¿°Áõ(UTI) ¹× ¿äµµÆó»öÀ¸·Î °íÅë¹Þ´Â ȯÀÚ°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ¿ä·Î ¹× »ý½Ä ±â°üÀÇ Á¾¾ç Áõ°¡¿Í ÇÔ²² ½ÃÀåÀ» ÃËÁøÇÏ´Â Áß¿äÇÑ ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ ¹æ±¤¿°, Àü¸³¼± ºñ´ëÁõ, ½ÅÀå °á¼®°ú °°Àº ºñ´¢±â ÁúȯÀÇ À¯º´·üÀÌ ´ëÁßµé »çÀÌ¿¡¼­ Áõ°¡Çϰí ÀÖ´Â °Íµµ ¾÷°è ÅõÀÚÀڵ鿡°Ô À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ ¿Ü¿¡µµ ô¼ö ¼Õ»ó, ´Ù¹ß¼º °æÈ­Áõ, Ä¡¸Å µî ´Ù¾çÇÑ Áúȯ¿¡¼­ °£Çæ½Ä Ä«Å×ÅÍ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ±Þ¼ºÀåÇÏ´Â ÇコÄÉ¾î »ê¾÷°ú ÇÔ²² ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷Àº ¿¬±¸°³¹ß(R&D) Ȱµ¿¿¡ Àû±ØÀûÀ¸·Î ÅõÀÚÇϰí ÀÖÀ¸¸ç, 2Â÷ °¨¿°À¸·ÎºÎÅÍÀÇ º¸È£¸¦ °­È­Çϱâ À§ÇØ ¿Âµµ ¸ð´ÏÅ͸µ ±â´ÉÀÌ ÀÖ´Â ÄÚÆÃµÈ ¿äµµ Ä«Å×Å͸¦ µµÀÔÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·á±â°üÀ» ¹æ¹®ÇÏ¿© Ä¡·á¸¦ ¹ÞÀ» ¼ö ¾ø´Â ȯÀÚµéÀ» À§ÇØ ¿Â¶óÀÎ »ó´ã ¹× ¾È³»¸¦ Á¦°øÇÏ´Â Ç÷§ÆûÀ» ±¸ÃàÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ Ä£¼ö¼º Ç×±Õ °£Çæ½Ä Ä«Å×ÅÍ¿Í °°Àº »õ·Î¿î Ä«Å×ÅÍ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϸ鼭 ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®

  • 2023³â ¼¼°èÀÇ °£Çæ½Ä Ä«Å×ÅÍ ½ÃÀå ±Ô¸ð´Â?
  • 2024-2032³â ¼¼°èÀÇ °£Çæ½Ä Ä«Å×ÅÍ ½ÃÀåÀÇ ¿¹»ó ¼ºÀå·üÀº?
  • ¼¼°èÀÇ °£Çæ½Ä Ä«Å×ÅÍ ½ÃÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡?
  • COVID-19°¡ ¼¼°èÀÇ °£Çæ½Ä Ä«Å×ÅÍ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀº?
  • ¼¼°èÀÇ °£Çæ½Ä Ä«Å×ÅÍ ½ÃÀå Á¦Ç°º° ºÐ·ù´Â?
  • ¼¼°èÀÇ °£Çæ½Ä Ä«Å×ÅÍ ½ÃÀå ÀûÀÀÁõº° ºÐ·ù´Â?
  • ¼¼°èÀÇ °£Çæ½Ä Ä«Å×ÅÍ ½ÃÀå Ä«Å×°í¸®º° ºÐ·ù´Â?
  • ¼¼°èÀÇ °£Çæ½Ä Ä«Å×ÅÍ ½ÃÀå ÃÖÁ¾»ç¿ëÀÚº° ºÐ·ù´Â?
  • ¼¼°èÀÇ °£Çæ½Ä Ä«Å×ÅÍ ½ÃÀå¿¡¼­ ÁÖ¿ä Áö¿ªÀº?
  • ¼¼°èÀÇ °£Çæ½Ä Ä«Å×ÅÍ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»ç ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • º¸ÅÒ¾÷ ¾îÇÁ·ÎÄ¡
    • Åé´Ù¿î ¾îÇÁ·ÎÄ¡
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼­·Ð

  • °³¿ä
  • ÁÖ¿ä »ê¾÷ µ¿Çâ

Á¦5Àå ¼¼°èÀÇ °£Çæ½Ä Ä«Å×ÅÍ ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ³»¿ª : Á¦Ç°º°

  • ºñÄÚÆÃ °£Çæ½Ä Ä«Å×ÅÍ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ÄÚÆÃ °£Çæ½Ä Ä«Å×ÅÍ
    • ½ÃÀå µ¿Çâ
    • ÁÖ¿ä ºÎ¹®
    • Ç×±Õ¼º
    • Ä£¼ö¼º
    • ±âŸ
    • ½ÃÀå ¿¹Ãø

Á¦7Àå ½ÃÀå ³»¿ª : ÀûÀÀÁõº°

  • ¿ä½Ç±Ý
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ¼ö¼ú(ÁÖ¿ä ¼ö¼ú)
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ô¼ö ¼Õ»ó
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ±âŸ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦8Àå ½ÃÀå ³»¿ª : Ä«Å×°í¸®º°

  • ³²¼º¿ë Ä«Å×ÅÍ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ¼Ò¾Æ¿ë Ä«Å×ÅÍ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ¿©¼º¿ë Ä«Å×ÅÍ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦9Àå ½ÃÀå ³»¿ª : ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ÀÇ·á ¿¬±¸ ¼¾ÅÍ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦10Àå ½ÃÀå ³»¿ª : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ij³ª´Ù
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ÀϺ»
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • Àεµ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • Çѱ¹
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • È£ÁÖ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • Àεµ³×½Ã¾Æ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ±âŸ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
  • À¯·´
    • µ¶ÀÏ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ÇÁ¶û½º
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ¿µ±¹
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ÀÌÅ»¸®¾Æ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ½ºÆäÀÎ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ·¯½Ã¾Æ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ±âŸ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ¸ß½ÃÄÚ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ±âŸ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ³»¿ª : ±¹°¡º°
    • ½ÃÀå ¿¹Ãø

Á¦11Àå SWOT ºÐ¼®

  • °³¿ä
  • °­Á¡
  • ¾àÁ¡
  • ±âȸ
  • À§Çù

Á¦12Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦13Àå Porter's Five Forces ºÐ¼®

  • °³¿ä
  • ±¸¸ÅÀÚÀÇ ±³¼··Â
  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • °æÀïÀÇ Á¤µµ
  • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦14Àå °¡°Ý ºÐ¼®

Á¦15Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ÀÇ °³¿ä
    • B. Braun Melsungen AG
    • Becton Dickinson and Company
    • Coloplast A/S
    • Cure Medical LLC(Convatec Group plc)
    • Hollister Incorporated
    • Hunter Urology
    • Medical Technologies of Georgia Inc.
    • Pennine Healthcare Ltd.
    • Teleflex Inc
    • Wellspect Limited(Dentsply Sirona)
KSA 24.04.17

The global intermittent catheters market size reached US$ 2.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.7 Billion by 2032, exhibiting a growth rate (CAGR) of 6.02% during 2024-2032.

Intermittent catheterization is a procedure of inserting and removing a catheter to drain urine from a bladder. It is an effective bladder management strategy for patients with incomplete bladder emptying due to idiopathic or neurogenic detrusor overactivity (NDO) dysfunction, inflammation, neurological conditions, pharmacological agents, and physical bladder obstruction. It is easy to use and convenient while preventing a distended bladder or a urinary tract infection (UTI). Besides this, as it avoids leaking, blockage, and bladder spasms, the demand for intermittent catheters are increasing across the globe.

Intermittent Catheters Market Trends:

At present, there is a rise in the number of patients suffering from urinary tract infections (UTIs) and blockages in the urethra around the world. This, along with the growing incidences of tumors in the urinary tract or reproductive organs, represents one of the key factors driving the market. Moreover, the rising prevalence of urological disorders, such as cystitis, benign prostatic hyperplasia, and kidney stones, among the masses is offering lucrative growth opportunities to industry investors. Besides this, there is an increase in the demand for intermittent catheters in various medical conditions, such as spinal cord injury, multiple sclerosis, or dementia. This, coupled with the burgeoning healthcare industry, is contributing to the growth of the market. In addition, key market players are extensively investing in research and development (R&D) activities to introduce coated urine catheters with temperature monitoring for enhanced protection against secondary infections. They are also launching platforms for providing online counseling and guidance to patients who cannot visit healthcare facilities for treatment. Apart from this, the escalating demand for novel catheters, such as hydrophilic antimicrobial intermittent catheters, is bolstering the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global intermittent catheters market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, indication, category and end user.

Breakup by Product:

Uncoated Intermittent Catheter

Coated Intermittent Catheter

Antimicrobial

Hydrophilic

Others

Breakup by Indication:

Urinary Incontinence

Surgery (Major Surgery)

Spinal Cord Injury

Others

Breakup by Category:

Male Length Catheter

Kids Length Catheter

Female Length Catheter

Breakup by End User:

Hospitals

Medical Research Centers

Ambulatory Surgical Centers

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Becton Dickinson and Company, Coloplast A/S, Cure Medical LLC (Convatec Group plc), Hollister Incorporated, Hunter Urology, Medical Technologies of Georgia Inc., Pennine Healthcare Ltd., Teleflex Inc and Wellspect Limited (Dentsply Sirona).

Key Questions Answered in This Report

  • 1. What was the size of the global intermittent catheters market in 2023?
  • 2. What is the expected growth rate of the global intermittent catheters market during 2024-2032?
  • 3. What are the key factors driving the global intermittent catheters market?
  • 4. What has been the impact of COVID-19 on the global intermittent catheters market?
  • 5. What is the breakup of the global intermittent catheters market based on the product?
  • 6. What is the breakup of the global intermittent catheters market based on the indication?
  • 7. What is the breakup of the global intermittent catheters market based on category?
  • 8. What is the breakup of the global intermittent catheters market based on the end user?
  • 9. What are the key regions in the global intermittent catheters market?
  • 10. Who are the key players/companies in the global intermittent catheters market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Intermittent Catheters Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Uncoated Intermittent Catheter
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Coated Intermittent Catheter
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
    • 6.2.1 Antimicrobial
    • 6.2.2 Hydrophilic
    • 6.2.3 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Indication

  • 7.1 Urinary Incontinence
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Surgery (Major Surgery)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Spinal Cord Injury
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Category

  • 8.1 Male Length Catheter
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Kids Length Catheter
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Female Length Catheter
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Medical Research Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Ambulatory Surgical Centers
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 B. Braun Melsungen AG
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Becton Dickinson and Company
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Coloplast A/S
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Cure Medical LLC (Convatec Group plc)
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Hollister Incorporated
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 SWOT Analysis
    • 15.3.6 Hunter Urology
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Medical Technologies of Georgia Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Pennine Healthcare Ltd.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Teleflex Inc
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Wellspect Limited (Dentsply Sirona)
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦